Palonosetron Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Palonosetron Hydrochloride Injection (injection) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Nov 14, 2025.

Shortage details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0703-4094-01
Dosage Form
Injection
Presentation
Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01)
Initial Posting
Nov 14, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.